In addition, a study of 3,000 cancer tissue samples from 12 tumor types revealed that most mutations were present in common oncogenic pathways RTK/RAS/RAF, PI3K/AKT/mTOR, cell cycle and p53-DNA repair, with the first route being affected in about half of the tumor samples 17. This evidence concerns the gene PIK3CA and neoplasm.